Quark Pharmaceuticals Overview
- Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
54
- Latest Deal Type
-
M&A
- Financing Rounds
-
14
- Investments
-
1
Quark Pharmaceuticals General Information
Description
Developer of therapeutic Ribonucleic acid interference (RNAi) drugs based in Newark, California. The company offers services catering to the discovery and development of novel small interfering RNA (siRNA) therapeutics for renal protection in cardio-renal disease and neuroprotection in ophthalmology.
Contact Information
Website
www.quarkpharma.com
Formerly Known As
Quark Biotech
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 7999 Gateway Boulevard
- Suite 310
- Newark, CA 94560
- United States
Quark Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Quark Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of therapeutic Ribonucleic acid interference (RNAi) drugs based in Newark, California. The company offers serv
Drug Discovery
Newark, CA
54
As of 2016
00000
000000&0
0000 0
nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt
0000 000000000
San Diego, CA
00
As of 0000
00000
00000000
00000
000000
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repre
0000 000000000
Toronto, Canada
00
As of 0000
000.00
00000
000.00
Add Comparison
Quark Pharmaceuticals Competitors (46)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| aTyr Pharma | Formerly VC-backed | San Diego, CA | 00 | 00000 | 00000000 | 00000 |
| 0000000 | Venture Capital-Backed | Toronto, Canada | 00 | 000.00 | 00000 | 000.00 |
| 000000000 | Formerly VC-backed | South San Francisco, CA | 00 | 000.00 | 00000000 | 000.00 |
| 000000000 | Formerly VC-backed | Vancouver, Canada | 000 | 00000 | 00000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 000000000 | 00000 |
Quark Pharmaceuticals Patents
Quark Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201413538-D0 | Ophthalmic compositions and uses thereof | Ceased | 30-Jul-2014 | 0000000000 | |
| JP-2020128383-A | Methods and compositions for preventing ischemia-reperfusion injury in organs | Pending | 29-May-2014 | 000000000 | |
| EP-3444349-B1 | Methods and compositions for preventing ischemia reperfusion injury in organs | Active | 29-May-2014 | 000000000 | |
| JP-2017521374-A | Methods and compositions for preventing ischemia-reperfusion injury of organs | Withdrawn | 29-May-2014 | 00000000000 | |
| ES-2862185-T3 | Methods and compositions to avoid ischemia-reperfusion injury to organs | Active | 29-May-2014 | C12N15/1135 |
Quark Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Quark Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Quark Pharmaceuticals Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 01-Sep-2012 | 00000 0000 | Pharmaceuticals |